2 blue chip ASX 200 shares analysts love

Here are two blue chips that analysts rate highly…

| More on:
man looking through window at sky scraper buildings

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors that are looking to bolster their portfolio with some blue chip ASX 200 shares may want to look at the three listed below.

Here's why these blue chip ASX 200 shares are highly rated:

BHP Group Ltd (ASX: BHP)

The first blue chip ASX 200 share to look at is BHP. The Big Australian's shares have come under significant pressure in recent months and now trade well below their 52-week high.

This has been driven largely by the falling iron ore price. However, with the steel making ingredient appearing to stabilise in or around the US$95 a tonne mark and other commodities performing strongly, this share price weakness could have been an overreaction.

The team at Morgans appear to believe this is the case. Last month the broker upgraded BHP's shares to an add rating with a $46.05 price target.

Healius Ltd (ASX: HLS)

Another blue chip ASX 200 share to look at is Healius. It is one of Australia's largest pathology and diagnostic imaging providers offering services via a number of brands. These include Dorevitch Pathology, QML Pathology, Laverty Pathology, and Healthcare Imaging Services.

Healius was a very positive performer in FY 2021. For the 12 months ended 30 June, the company reported a 22% increase in revenue to $1,913.1 million and the doubling of its underlying EBIT to $266.5 million.

A key driver of this growth was its pathology business, which is experiencing significant demand for COVID-19 testing services. Pleasingly, demand remains strong and has underpinned further explosive growth so far in FY 2022.

For example, during the first quarter of FY 2022, Healius was averaging 40,000 COVID tests per working day. This supported a 43.7% increase in group quarterly revenue over the prior corresponding period to $689.9 million.

Macquarie is a big fan of the company. It currently has an outperform rating and $5.65 price target on Healius' shares. In addition, it expects a dividend yield of almost 5% in FY 2022.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

A young man punches the air in delight as he reacts to great news on his mobile phone.
Blue Chip Shares

4 excellent ASX 200 blue chip shares to buy in 2025

If you are in the process of building an investment portfolio, then having a few ASX 200 blue chip shares in there…

Read more »

A couple makes silly chip moustache faces and take a selfie on their phone.
Blue Chip Shares

I think these are the 3 best ASX blue-chip shares for dividends

There are only a few big companies I’d want to own.

Read more »

A happy older couple relax in a hammock together as they think about enjoying life with a passive income stream.
Blue Chip Shares

Buy these quality ASX blue chip shares for a passive income boost

Analysts think these blue chips could be great options for investors searching for passive income.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

3 excellent ASX 200 blue chip shares to buy in 2025

Analysts have good things to say about these blue chips.

Read more »

A fit man flexes his muscles, indicating a positive share price movement on the ASX market
Blue Chip Shares

3 strong ASX 200 blue chip stocks to buy with $2,000 in December

These blue chips have been given the thumbs up from analysts.

Read more »

A share market analyst looks at his computer screen in front of him showing ASX share price movements
Blue Chip Shares

Analysts name 3 strong blue chip ASX 200 shares to buy in December

Let's see which blue chips are bring tipped as buys by analysts right now.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Blue Chip Shares

Buy these 3 high-quality ASX 200 blue chip shares in December

Analysts think these high-quality shares are buys right now. Let's see what they are saying.

Read more »

Two people comparing and analysing material.
Blue Chip Shares

Are Woodside or CBA shares a better buy?

Here’s how I’d compare these two major ASX blue chips.

Read more »